AQR Capital Management
KNSA icon

AQR Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

AQR Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24M Sell
375,039
-3,658
-1% -$190K 0.01% 1101
2026
Q1 		$18.2M Buy
378,697
+25,635
+7% +$1.14M 0.01% 1068
2025
Q4 		$14.6M Buy
353,062
+20,645
+6% +$828K 0.01% 1051
2025
Q3 		$12.9M Sell
332,417
-65,815
-17% -$2.14M 0.01% 990
2025
Q2 		$11M Sell
398,232
-93,529
-19% -$2.38M 0.01% 937
2025
Q1 		$10.9M Buy
491,761
+294,319
+149% +$6.06M 0.01% 847
2024
Q4 		$3.91M Buy
197,442
+13,273
+7% +$303K 0.01% 1211
2024
Q3 		$4.6M Buy
184,169
+58,174
+46% +$1.42M 0.01% 1096
2024
Q2 		$2.35M Sell
125,995
-33,328
-21% -$624K ﹤0.01% 1386
2024
Q1 		$3.14M Sell
159,323
-68,722
-30% -$1.34M 0.01% 1211
2023
Q4 		$4M Sell
228,045
-95,533
-30% -$1.57M 0.01% 1045
2023
Q3 		$5.62M Sell
323,578
-187,444
-37% -$3.16M 0.01% 868
2023
Q2 		$7.2M Buy
511,022
+103,260
+25% +$1.38M 0.02% 761
2023
Q1 		$4.39M Buy
407,762
+262,747
+181% +$3.46M 0.01% 950
2022
Q4 		$2.17M Buy
+145,015
New +$2.11M ﹤0.01% 1218
2021
Q1 		– Sell
-15,390
Closed -$272K – 2232
2020
Q4 		$272K Sell
15,390
-2,868
-16% -$50.4K ﹤0.01% 1999
2020
Q3 		$280K Buy
18,258
+7,017
+62% +$132K ﹤0.01% 1942
2020
Q2 		$286K Buy
+11,241
New +$235K ﹤0.01% 1902

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

AQR Capital Management's KNSA Position: Q2 2026 in Review

AQR Capital Management reduced its Kiniksa Pharmaceuticals (KNSA) stake by 0.97% in Q2 2026, selling an estimated $190K and leaving 375,039 shares worth $24M. The position accounts for 0.01% of the portfolio, ranked #1101.

AQR Capital Management first reported a position in KNSA in Q2 2020 and has held it in 18 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • AQR Capital Management held 375,039 shares of Kiniksa Pharmaceuticals worth $24M as of Q2 2026.
  • AQR Capital Management sold 3,658 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $190K.
  • Kiniksa Pharmaceuticals made up 0.01% of AQR Capital Management's portfolio in Q2 2026, its #1101 holding.
  • AQR Capital Management first reported a position in Kiniksa Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.